Purchase Order 75N91024P00060
Award Date 11/8/23
Potential Completion Date 1/8/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,822 purchase order to Central Brain Tumor Registry of the United States for laboratory testing services. The firm fixed price contract has a period of performance from September 1, 2023 through December 31, 2023. The place of performance will be in Hinsdale, Illinois. The National Cancer Institute supports research related to cancer causes, prevention, diagnosis, and treatment...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $3,547.70 firm fixed price delivery order contract to Olgoonik Federal LLC. The contract, numbered NCI-23-099, will be performed in Bethesda, Maryland from July 24, 2023 through October 24, 2023. The National Cancer Institute is the federal agency responsible for cancer research within the United States. While details of the products or services requested were not provided, this delivery...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $24,806.85 firm fixed price purchase order to Miltenyi Biotec, Inc. for laboratory equipment. The place of performance is Auburn, California and the period of performance is from September 12, 2023 through October 12, 2023. The National Cancer Institute conducts and supports research aimed at discovering prevention and cures for cancer. This purchase order for laboratory...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,570 purchase order to Oxford Nanopore Technologies Inc. for laboratory supplies. The firm fixed price contract runs from August 17, 2023 to January 5, 2024 and will be performed in New York, New York. As the National Cancer Institute supports research to advance cancer prevention, diagnosis, and treatment, this contract will likely provide supplies to enable NCI-funded laboratory...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,000 firm fixed price purchase order to Caerus US 1 Inc. for SOFTWARE. The place of performance is New York, NY. The one year contract starts on July 26, 2023 and ends on July 25, 2024. No set aside designation or subcontractors were identified. The National Cancer Institute is a part of NIH focused on cancer research, so this contract is likely to deliver software products or...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,418 purchase order to the Regents of the University of Minnesota doing business as Office of Sponsored Projects Administration. The firm fixed price contract is for laboratory testing services and will be performed in Minneapolis, Minnesota over a one year period from September 2023 through September 2024. No major subcontractors or set aside designations were indicated. The National...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,922 firm fixed price purchase order to Baylor College of Medicine for testing services. The contract has a period of performance from November 8, 2023 through January 8, 2024 and will be performed in Houston, Texas. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for cancer research within the United States and supports a wide range of biomedical research efforts, clinical trials networks, and cancer centers. This purchase order is likely supporting laboratory or clinical testing to advance the NIH's cancer research mission.
Generated 12/20/23, 4:18 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 11/7/23 |